Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""SALVAGE therapy"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 318
Tytuł:
Salvage cryotherapy for prostate cancer.
Autorzy:
E Brito DV; Urology Department Portuguese Institute of Oncology Coimbra. .
Pereira JA; Urology Department Portuguese Institute of Oncology Coimbra. .
Ferreira AM; Urology Department Portuguese Institute of Oncology Coimbra. .
Lourenço M; Urology Department Portuguese Institute of Oncology Coimbra. .
Godinho R; Urology Department Portuguese Institute of Oncology Coimbra. .
Pereira B; Urology Department Portuguese Institute of Oncology Coimbra. .
Peralta P; Urology Department Portuguese Institute of Oncology Coimbra. .
Conceiçao P; Urology Department Portuguese Institute of Oncology Coimbra. .
Reis M; Urology Department Portuguese Institute of Oncology Coimbra. .
Rabaça C; Urology Department Portuguese Institute of Oncology Coimbra. .
Pokaż więcej
Źródło:
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica [Arch Ital Urol Androl] 2024 Jan 08; Vol. 95 (4), pp. 11897. Date of Electronic Publication: 2024 Jan 08.
Typ publikacji:
Journal Article
MeSH Terms:
Cryotherapy*
Prostatic Neoplasms*/therapy
Male ; Humans ; Middle Aged ; Aged ; Prostate ; Pelvis ; Salvage Therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml.
Autorzy:
Solomonidou N; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
Germanou D; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
Strouthos I; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
Karagiannis E; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
Farolfi A; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Koerber SA; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
Peeken JC; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; Department of Radiation Sciences (DRS), Institute of Radiation Medicine (IRM), Helmholtz Zentrum, Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
Vogel ME; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; Department of Radiation Sciences (DRS), Institute of Radiation Medicine (IRM), Helmholtz Zentrum, Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
Vrachimis A; Department of Nuclear Medicine, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.; C.A.R.I.C. Cancer Research & Innovation Center, Limassol, Cyprus.
Spohn SKB; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg im Breisgau, Germany.; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Shelan M; Department of Radiation Oncology, Inselspital Bern, University of Bern, Bern, Switzerland.
Aebersold D; Department of Radiation Oncology, Inselspital Bern, University of Bern, Bern, Switzerland.
Grosu AL; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg im Breisgau, Germany.
Ceci F; Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Kroeze SGC; Northern Sydney Cancer Centre, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia.
Guckenberger M; Northern Sydney Cancer Centre, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia.
Fanti S; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Hruby G; Northern Sydney Cancer Centre, Royal North Shore Hospital, University of Sydney, Sydney, New South Wales, Australia.
Scharl S; Department of Radiation Oncology, University of Ulm, Ulm, Germany.
Wiegel T; Department of Radiation Oncology, University of Ulm, Ulm, Germany.
Bartenstein P; Department of Nuclear MedicineUniversity Hospital, LMU Munich, Munich, Germany.
Henkenberens C; Department of Radiotherapy and Special Oncology, Medical School Hannover, Hannover, Germany.
Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, Australia.; St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
Schmidt-Hegemann NS; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Ferentinos K; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
Zamboglou C; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany. .; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg im Breisgau, Germany. .; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany. .; German Oncology Center, University Hospital of the European University Cyprus, Limassol, Cyprus. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2529-2536. Date of Electronic Publication: 2023 Mar 11.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Male ; Humans ; Prostate-Specific Antigen ; Positron Emission Tomography Computed Tomography/methods ; Gallium Radioisotopes ; Retrospective Studies ; Androgen Antagonists ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/radiotherapy ; Salvage Therapy ; Prostatectomy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Salvage radiotherapy after radical prostatectomy: functional outcomes in the LAPPRO trial after 8-year follow-up.
Autorzy:
Carlsson S; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden. .
Bock D; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Scandinavian Surgical Outcomes Research Group, Gothenburg, Sweden.
Lantz A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden; Division of Biostatistics, IMM, Karolinska Institutet, Stockholm, Sweden.
Angenete E; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Scandinavian Surgical Outcomes Research Group, Gothenburg, Sweden; Department of Surgery, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden.
Koss Modig K; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Urology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Hugosson J; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Urology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Bjartell A; Department of Urology, Skåne University Hospital, Malmö, Sweden; Department of Translational Medicine, Division of Urological Cancers, Lund University, Lund, Sweden.
Steineck G; Department of Oncology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Wiklund P; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden; Department of Urology, Icahn School of Medicine at Mount Sinai Health System, New York, NY, USA.
Haglind E; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Scandinavian Surgical Outcomes Research Group, Gothenburg, Sweden; Department of Surgery, Region Västra Götaland, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden.
Pokaż więcej
Źródło:
Scandinavian journal of urology [Scand J Urol] 2023 May 11; Vol. 58, pp. 11-19. Date of Electronic Publication: 2023 May 11.
Typ publikacji:
Controlled Clinical Trial; Journal Article
MeSH Terms:
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Urinary Incontinence*/epidemiology
Urinary Incontinence*/etiology
Male ; Humans ; Follow-Up Studies ; Prospective Studies ; Hematuria/etiology ; Prostatectomy/adverse effects ; Prostatectomy/methods ; Salvage Therapy/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Salvage HDR brachytherapy for prostate cancer: a high-volume center experience on 100 consecutive patients.
Autorzy:
Mäkelä L; Comprehensive Cancer Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Bergroth R; Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Taipale L; Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Tornberg S; Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Visapää H; Comprehensive Cancer Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Pokaż więcej
Źródło:
Scandinavian journal of urology [Scand J Urol] 2023 Feb-Dec; Vol. 57 (1-6), pp. 36-40. Date of Electronic Publication: 2023 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Brachytherapy*/methods
Prostatic Neoplasms*/pathology
Male ; Humans ; Retrospective Studies ; Neoplasm Recurrence, Local/pathology ; Treatment Outcome ; Salvage Therapy/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
How can we best manage biochemical failure after radical prostatectomy?
Autorzy:
Kim WT; Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea.
Kim J; Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Kim WJ; Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea.; Institute of Urotech, Cheongju, Korea. .
Pokaż więcej
Źródło:
Investigative and clinical urology [Investig Clin Urol] 2022 Nov; Vol. 63 (6), pp. 592-601.
Typ publikacji:
Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Prostate*
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/radiotherapy
Male ; Humans ; Androgen Antagonists/therapeutic use ; Neoplasm Recurrence, Local/surgery ; Prostatectomy/adverse effects ; Prostatectomy/methods ; Prostate-Specific Antigen ; Salvage Therapy/methods ; Disease Progression ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Defining the optimal template of salvage lymph node dissection for unilateral pelvic nodal recurrence of prostate cancer following radical prostatectomy.
Autorzy:
Van Eecke H; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
Devos G; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
Vansevenant B; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Vander Stichele A; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
Devlies W; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Berghen C; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.
Everaerts W; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
De Meerleer G; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.
Joniau S; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Pokaż więcej
Źródło:
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2023 Jan; Vol. 30 (1), pp. 92-99. Date of Electronic Publication: 2022 Oct 28.
Typ publikacji:
Journal Article
MeSH Terms:
Positron Emission Tomography Computed Tomography*/methods
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Male ; Humans ; Retrospective Studies ; Lymph Node Excision/methods ; Lymph Nodes/diagnostic imaging ; Lymph Nodes/surgery ; Lymph Nodes/pathology ; Prostatectomy/methods ; Pelvis/pathology ; Salvage Therapy/methods ; Neoplasm Recurrence, Local/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Medium-term oncological outcomes of intermediate-risk prostate cancer treated with HIFU or cryotherapy. A single center 10-year experience.
Autorzy:
Dias N; Urology Department, Institut Mutualiste Montsouris, Paris, France; Urology Department, São João Hospitalar and University Center, Porto. .
Rodriguez-Sanchez L; Urology Department, Institut Mutualiste Montsouris, Paris. .
Colandrea G; Urology Department, Institut Mutualiste Montsouris, Paris, France; Unit of Urology, Division of Experimental Oncology, URI Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan. .
Macek P; Urology Department, Institut Mutualiste Montsouris, Paris. .
Cathelineau X; Urology Department, Institut Mutualiste Montsouris, Paris. .
Pokaż więcej
Źródło:
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica [Arch Ital Urol Androl] 2022 Dec 27; Vol. 94 (4), pp. 413-419. Date of Electronic Publication: 2022 Dec 27.
Typ publikacji:
Journal Article
MeSH Terms:
Prostate-Specific Antigen*
Prostatic Neoplasms*/therapy
Prostatic Neoplasms*/pathology
Male ; Humans ; Aged ; Treatment Outcome ; Cryotherapy ; Salvage Therapy/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer.
Autorzy:
van Riel LAMJG; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Geboers B; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.
Kabaktepe E; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Blazevski A; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.
Reesink DJ; Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Stijns P; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.
Stricker PD; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Casanova J; Department of Urology, Instituto Valenciano de Oncologia, València, Spain.
Dominguez-Escrig JL; Department of Urology, Instituto Valenciano de Oncologia, València, Spain.
de Reijke TM; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Scheltema MJ; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Garvan Institute of Medical Research, Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.
Oddens JR; Department of Urology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Nov; Vol. 130 (5), pp. 611-618. Date of Electronic Publication: 2022 May 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Erectile Dysfunction*/etiology
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Male ; Humans ; Middle Aged ; Prostate-Specific Antigen ; Retrospective Studies ; Quality of Life ; Neoplasm Recurrence, Local/therapy ; Treatment Outcome ; Prostatectomy/adverse effects ; Prostatectomy/methods ; Salvage Therapy/methods ; Electroporation/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Optimal Definition of Biochemical Recurrence in Patients Who Receive Salvage Radiotherapy Following Radical Prostatectomy for Prostate Cancer.
Autorzy:
Lee SU; The Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Kim JS; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Kim YS; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Cho J; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Choi SH; Department of Radiation Oncology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Nam TK; Department of Radiation Oncology, Chonnam National University Hwasun Hospital, Chonnam National University College of Medicine, Hwasun, Korea.
Jeong SM; Department of Radiation Oncology, Ewha Womans University Medical Center, Ewha Womans University College of Medicine, Seoul, Korea.
Kim Y; Department of Radiation Oncology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea.
Choi Y; Department of Radiation Oncology, Dong-A University Hospital, Dong-A University School of Medicine, Busan, Korea.
Lee DE; Biostatistics Collaboration Team, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Park W; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Cho KH; The Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2022 Oct; Vol. 54 (4), pp. 1191-1199. Date of Electronic Publication: 2021 Dec 07.
Typ publikacji:
Journal Article
MeSH Terms:
Prostate-Specific Antigen*
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Hormones ; Humans ; Male ; Neoplasm Recurrence, Local/surgery ; Prostatectomy ; Retrospective Studies ; Salvage Therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches.
Autorzy:
Sekhoacha M; Department of Pharmacology, University of the Free State, Bloemfontein 9300, South Africa.
Riet K; Department of Health Sciences, Central University of Technology, Bloemfontein 9300, South Africa.
Motloung P; Department of Health Sciences, Central University of Technology, Bloemfontein 9300, South Africa.
Gumenku L; Department of Health Sciences, Central University of Technology, Bloemfontein 9300, South Africa.
Adegoke A; Department of Pharmacology, University of the Free State, Bloemfontein 9300, South Africa.; Cancer Research and Molecular Biology Laboratories, Department of Biochemistry, College of Medicine, University of Ibadan, Ibadan 200005, Nigeria.
Mashele S; Department of Health Sciences, Central University of Technology, Bloemfontein 9300, South Africa.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Sep 05; Vol. 27 (17). Date of Electronic Publication: 2022 Sep 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/therapy
Androgen Antagonists ; Humans ; Male ; Neoplasm Recurrence, Local ; Prostate-Specific Antigen ; Prostatectomy/adverse effects ; Salvage Therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Salvage radiotherapy following HiFU: An institutional series and literature review.
Autorzy:
Mesci A; Radiation Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada.; Department of Oncology, McMaster University, Hamilton, Ontario, Canada.; Radiation Oncology, Walker Family Cancer Centre, Niagara Health System, St. Catherines, Ontario, Canada.
Gouran-Savadkoohi M; Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
Ribeiro D; Radiotherapy, Juravinski Cancer Centre, Hamilton Health Sciences Centre, Hamilton, Ontario, Canada.
Dayes I; Radiation Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada.; Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
Lukka H; Radiation Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada.; Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
Schnarr K; Radiation Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada.; Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
Quan K; Radiation Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada.; Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
Goldberg M; Radiation Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada.; Department of Oncology, McMaster University, Hamilton, Ontario, Canada.
Hallock A; Radiation Oncology, Walker Family Cancer Centre, Niagara Health System, St. Catherines, Ontario, Canada.
Tsakiridis T; Radiation Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada.; Department of Oncology, McMaster University, Hamilton, Ontario, Canada.; Radiation Oncology, Walker Family Cancer Centre, Niagara Health System, St. Catherines, Ontario, Canada.
Pokaż więcej
Źródło:
Journal of medical imaging and radiation oncology [J Med Imaging Radiat Oncol] 2022 Sep; Vol. 66 (6), pp. 847-852. Date of Electronic Publication: 2022 Feb 16.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Prostate-Specific Antigen*
Prostatic Neoplasms*/radiotherapy
Androgen Antagonists ; Humans ; Male ; Neoplasm Recurrence, Local ; Salvage Therapy ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience.
Autorzy:
Murgic J; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Jaksic B; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Prpic M; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.; School of Dental Medicine, University of Zagreb, Gunduliceva 5, 10000, Zagreb, Croatia.
Kust D; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Bahl A; University Hospitals Bristol NHS Foundation Trust, Marlborough Street, Bristol, BS13NU, UK.
Budanec M; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Prgomet Secan A; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Franco P; Department of Translational Medicine, University of Eastern Piedmont, 28100, Novara, Italy.; Department of Radiation Oncology, 'Maggiore della Carità' University Hospital, 28100, Novara, Italy.
Kruljac I; Department of Endocrinology, Diabetes and Metabolic Diseases 'Mladen Sekso', University Hospital Center Sestre Milosrdnice, University of Zagreb School of Medicine, Vinogradska 29, 10000, Zagreb, Croatia.
Spajic B; Department of Urology, University Hospital Center Sestre Milosrdnice, 10000, Zagreb, Croatia.
Babic N; Department of Radiology, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Kruslin B; Ljudevit Jurak Department of Pathology and Cytology, Sestre Milosrdnice University Hospital Centre, Vinogradska 29, 10000, Zagreb, Croatia.
Zovak M; Department of Surgery, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia.
Zubizarreta E; Division of Human Health, International Atomic Energy Agency (IAEA), Wagramer Str. 5, 1220, Vienna, Austria.
Rosenblatt E; Division of Human Health, International Atomic Energy Agency (IAEA), Wagramer Str. 5, 1220, Vienna, Austria.
Fröbe A; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Vinogradska 29, 10000, Zagreb, Croatia. .; School of Dental Medicine, University of Zagreb, Gunduliceva 5, 10000, Zagreb, Croatia. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2021 May 12; Vol. 16 (1), pp. 88. Date of Electronic Publication: 2021 May 12.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article
MeSH Terms:
Dose Fractionation, Radiation*
Radiation Dose Hypofractionation*
Salvage Therapy*
Prostate-Specific Antigen/*blood
Prostatectomy/*mortality
Prostatic Neoplasms/*mortality
Radiotherapy, Intensity-Modulated/*mortality
Aged ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/radiotherapy ; Neoplasm Recurrence, Local/surgery ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/radiotherapy ; Prostatic Neoplasms/surgery ; Radiotherapy, Intensity-Modulated/methods ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Event-free survival after  Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy.
Autorzy:
Ceci F; Nuclear Medicine, Department of Medical Sciences, AOU Città Della Salute E Della Scienza Di Torino, University of Turin, Turin, Italy. .; Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy. .; Department of Oncology and Hemato-Oncolology, University of Milan, Milan, Italy. .; Nuclear Medicine Department, S. Croce E Carle Hospital, Cuneo, Italy. .
Rovera G; Nuclear Medicine, Department of Medical Sciences, AOU Città Della Salute E Della Scienza Di Torino, University of Turin, Turin, Italy.; Section of Nuclear Medicine, University Department of Radiological Sciences and Haematology, Università Cattolica del Sacro Cuore, Rome, Italy.
Iorio GC; Radiation Oncology, Department of Oncology, AOU Città Della Salute E Della Scienza Di Torino, Turin, Italy.
Guarneri A; Radiation Oncology, Department of Oncology, AOU Città Della Salute E Della Scienza Di Torino, Turin, Italy.
Chiofalo V; Radiation Oncology, Department of Oncology, AOU Città Della Salute E Della Scienza Di Torino, Turin, Italy.
Passera R; Nuclear Medicine, Department of Medical Sciences, AOU Città Della Salute E Della Scienza Di Torino, University of Turin, Turin, Italy.
Oderda M; Urology, Department of Surgical Sciences, AOU Città Della Salute E Della Scienza Di Torino, University of Turin, Turin, Italy.
Dall'Armellina S; Nuclear Medicine, Department of Medical Sciences, AOU Città Della Salute E Della Scienza Di Torino, University of Turin, Turin, Italy.
Liberini V; Nuclear Medicine, Department of Medical Sciences, AOU Città Della Salute E Della Scienza Di Torino, University of Turin, Turin, Italy.
Grimaldi S; Nuclear Medicine, Department of Medical Sciences, AOU Città Della Salute E Della Scienza Di Torino, University of Turin, Turin, Italy.
Bellò M; Nuclear Medicine, Department of Medical Sciences, AOU Città Della Salute E Della Scienza Di Torino, University of Turin, Turin, Italy.
Gontero P; Urology, Department of Surgical Sciences, AOU Città Della Salute E Della Scienza Di Torino, University of Turin, Turin, Italy.
Ricardi U; Section of Nuclear Medicine, University Department of Radiological Sciences and Haematology, Università Cattolica del Sacro Cuore, Rome, Italy.; Department of Oncology, University of Turin, Turin, Italy.
Deandreis D; Nuclear Medicine, Department of Medical Sciences, AOU Città Della Salute E Della Scienza Di Torino, University of Turin, Turin, Italy.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Jul; Vol. 49 (9), pp. 3257-3268. Date of Electronic Publication: 2022 Feb 26.
Typ publikacji:
Journal Article
MeSH Terms:
Positron Emission Tomography Computed Tomography*/methods
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/therapy
Edetic Acid ; Gallium Radioisotopes ; Humans ; Male ; Neoplasm Recurrence, Local/diagnostic imaging ; Oligopeptides ; Progression-Free Survival ; Prospective Studies ; Prostate-Specific Antigen ; Salvage Therapy/methods ; Tomography, X-Ray Computed
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Robot-assisted salvage seminal vesicle excision for isolated recurrence after low-dose-rate prostate brachytherapy.
Autorzy:
Langley S; The Stokes Centre for Urology, Royal Surrey Hospital NHS Foundation Trust, Guildford, UK.
Eden C; The Stokes Centre for Urology, Royal Surrey Hospital NHS Foundation Trust, Guildford, UK.
Perry M; The Stokes Centre for Urology, Royal Surrey Hospital NHS Foundation Trust, Guildford, UK.
Patil K; The Stokes Centre for Urology, Royal Surrey Hospital NHS Foundation Trust, Guildford, UK.
Moschonas D; The Stokes Centre for Urology, Royal Surrey Hospital NHS Foundation Trust, Guildford, UK.
Higgins D; The Stokes Centre for Urology, Royal Surrey Hospital NHS Foundation Trust, Guildford, UK.
Deering C; The Stokes Centre for Urology, Royal Surrey Hospital NHS Foundation Trust, Guildford, UK.
Laing R; The Stokes Centre for Urology, Royal Surrey Hospital NHS Foundation Trust, Guildford, UK.
Perna C; The Stokes Centre for Urology, Royal Surrey Hospital NHS Foundation Trust, Guildford, UK.
Khaksar S; The Stokes Centre for Urology, Royal Surrey Hospital NHS Foundation Trust, Guildford, UK.
Uribe-Lewis S; The Stokes Centre for Urology, Royal Surrey Hospital NHS Foundation Trust, Guildford, UK.
Uribe J; The Stokes Centre for Urology, Royal Surrey Hospital NHS Foundation Trust, Guildford, UK.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 Jun; Vol. 129 (6), pp. 731-736. Date of Electronic Publication: 2021 Sep 14.
Typ publikacji:
Journal Article
MeSH Terms:
Brachytherapy*
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Robotic Surgical Procedures*
Seminal Vesicles*/pathology
Seminal Vesicles*/surgery
Androgen Antagonists ; Biopsy ; Humans ; Male ; Neoplasm Recurrence, Local/pathology ; Positron Emission Tomography Computed Tomography ; Prostate/pathology ; Prostate-Specific Antigen ; Salvage Therapy/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Introduction of salvage prostatectomy in Denmark: the initial experience.
Autorzy:
Mortensen MA; Department of Urology, Odense University Hospital, Odense, Denmark. .
Poulsen CA; Department of Urology, Odense University Hospital, Odense, Denmark.
Ahlgren G; Peritus Clinic, Lund, Sweden.
Madsen K; Department of Pathology, Odense University Hospital, Odense, Denmark.; Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Poulsen MH; Department of Urology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Pokaż więcej
Źródło:
BMC research notes [BMC Res Notes] 2022 May 21; Vol. 15 (1), pp. 185. Date of Electronic Publication: 2022 May 21.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/surgery
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Robotic Surgical Procedures*
Denmark ; Humans ; Male ; Pilot Projects ; Prostate-Specific Antigen ; Prostatectomy/methods ; Retrospective Studies ; Salvage Therapy/methods ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Phase III randomised controlled trial on PSMA PET/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): study protocol.
Autorzy:
Staal FHE; Department of Radiation Oncology, University Medical Centre Groningen, Hanzeplein 1, Postbus 30 001, 9700, RB, Groningen, The Netherlands. .
Janssen J; Department of Radiation Oncology, University Medical Centre Groningen, Hanzeplein 1, Postbus 30 001, 9700, RB, Groningen, The Netherlands.
Brouwer CL; Department of Radiation Oncology, University Medical Centre Groningen, Hanzeplein 1, Postbus 30 001, 9700, RB, Groningen, The Netherlands.
Langendijk JA; Department of Radiation Oncology, University Medical Centre Groningen, Hanzeplein 1, Postbus 30 001, 9700, RB, Groningen, The Netherlands.
Ng Wei Siang K; Department of Radiation Oncology, University Medical Centre Groningen, Hanzeplein 1, Postbus 30 001, 9700, RB, Groningen, The Netherlands.
Schuit E; Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
de Jong IJ; Department of Urology, University Medical Centre Groningen, Groningen, The Netherlands.
Verzijlbergen JF; Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Smeenk RJ; Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Aluwini S; Department of Radiation Oncology, University Medical Centre Groningen, Hanzeplein 1, Postbus 30 001, 9700, RB, Groningen, The Netherlands.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Apr 15; Vol. 22 (1), pp. 416. Date of Electronic Publication: 2022 Apr 15.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Positron Emission Tomography Computed Tomography*/methods
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Clinical Trials, Phase III as Topic ; Gallium Isotopes ; Gallium Radioisotopes ; Humans ; Male ; Multicenter Studies as Topic ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/radiotherapy ; Neoplasm Recurrence, Local/surgery ; Prospective Studies ; Prostate/pathology ; Prostate-Specific Antigen ; Prostatectomy/methods ; Quality of Life ; Radiation Dose Hypofractionation ; Randomized Controlled Trials as Topic ; Salvage Therapy/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer.
Autorzy:
Tsumura H; Department of Urology, Kitasato University School of Medicine, 1-15-1 Kitasato Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. .
Tanaka N; Department of Urology, Nara Medical University, Kashihara, Japan.
Oguchi T; Department of Urology, Nagano Municipal Hospital, Nagano, Japan.
Owari T; Department of Urology, Nara Medical University, Kashihara, Japan.
Nakai Y; Department of Urology, Nara Medical University, Kashihara, Japan.
Asakawa I; Department of Radiation Oncology, Nara Medical University, Kashihara, Japan.
Iijima K; Department of Urology, Nagano Municipal Hospital, Nagano, Japan.
Kato H; Department of Urology, Nagano Municipal Hospital, Nagano, Japan.
Hashida I; Department of Radiation Therapy, Nagano Municipal Hospital, Nagano, Japan.
Tabata KI; Department of Urology, Kitasato University School of Medicine, 1-15-1 Kitasato Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan.
Satoh T; Department of Urology, Kitasato University School of Medicine, 1-15-1 Kitasato Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan.
Ishiyama H; Department of Radiation Oncology, Kitasato University School of Medicine, Sagamihara, Japan.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2022 Apr 11; Vol. 17 (1), pp. 71. Date of Electronic Publication: 2022 Apr 11.
Typ publikacji:
Journal Article
MeSH Terms:
Brachytherapy*/adverse effects
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Humans ; Male ; Neoplasm Recurrence, Local/surgery ; Prostate-Specific Antigen ; Prostatectomy/adverse effects ; Retrospective Studies ; Salvage Therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adjuvant versus early Salvage radiation therapy for prostate cancer with adverse pathological features on radical prostatectomy-Do we finally have an answer?
Autorzy:
Jain S; Department of Gen. Surgery, Gandhi Medical College, Bhopal, Madhya Pradesh, India.
Mallick I; Department of Radiation Oncology, Tata Medical Centre, Kolkata, West Bengal, India.
Tamhankar AS; Department of Urology, East and North Hertfordshire NHS Trust, Lister Hospital, UK.
Gautam G; Department of Surgical Oncology, Division of Urologic Oncology, Max Institute of Cancer Care, Saket, New Delhi, India.
Pokaż więcej
Źródło:
Indian journal of cancer [Indian J Cancer] 2022 Apr-Jun; Vol. 59 (2), pp. 170-177.
Typ publikacji:
Journal Article; Review; Systematic Review
MeSH Terms:
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Seminal Vesicles*/pathology
Humans ; Male ; Neoplasm Recurrence, Local/radiotherapy ; Neoplasm Recurrence, Local/surgery ; Prostate-Specific Antigen ; Prostatectomy ; Radiotherapy, Adjuvant/adverse effects ; Retrospective Studies ; Salvage Therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy.
Autorzy:
Rogowski P; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. .
Trapp C; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
von Bestenbostel R; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Eze C; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Ganswindt U; Department of Radiation Oncology, University Hospital, Medical University Innsbruck, Innsbruck, Austria.
Li M; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Unterrainer M; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Zacherl MJ; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Ilhan H; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Beyer L; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Kretschmer A; Department of Urology, University Hospital, LMU Munich, Munich, Germany.
Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Stief C; Department of Urology, University Hospital, LMU Munich, Munich, Germany.
Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Munich, Germany.
Schmidt-Hegemann NS; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Mar; Vol. 49 (4), pp. 1417-1428. Date of Electronic Publication: 2021 Oct 10.
Typ publikacji:
Journal Article
MeSH Terms:
Positron Emission Tomography Computed Tomography*
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Androgen Antagonists ; Gallium Radioisotopes ; Humans ; Lymphatic Metastasis ; Male ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Prostate-Specific Antigen ; Prostatectomy ; Retrospective Studies ; Salvage Therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy.
Autorzy:
Nair SM; Division of Urology, Department of Surgery, Western University, London, ON, Canada.
Stern N; Division of Urology, Department of Surgery, Western University, London, ON, Canada.
Dewar M; Life Kingsbury Hospital, Cape Town, South Africa.
Siddiqui K; Department of Surgery, Sultan Qaboos University Hospital, Muscat, Oman.
Smith E; University of Toronto, Toronto, ON, Canada.
Gomez JA; Department of Pathology, Western University, London, ON, Canada.
Moussa M; Department of Pathology, Western University, London, ON, Canada.
Chin JL; Division of Urology, Department of Surgery, Western University, London, ON, Canada.
Pokaż więcej
Źródło:
Scandinavian journal of urology [Scand J Urol] 2020 Jun; Vol. 54 (3), pp. 215-219. Date of Electronic Publication: 2020 Apr 20.
Typ publikacji:
Journal Article
MeSH Terms:
Magnetic Resonance Imaging*
Salvage Therapy*
Ultrasonic Surgical Procedures*/methods
Neoplasm Recurrence, Local/*surgery
Prostatectomy/*methods
Prostatic Neoplasms/*surgery
Ablation Techniques ; Aged ; Feasibility Studies ; Humans ; Male ; Surgery, Computer-Assisted ; Treatment Outcome ; Urethra
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 318

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies